Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
about
Plasma cell leukemia: concepts and management.Role of polymer-drug conjugates in organ-specific delivery systems.Primary Plasma Cell Leukemia: Identity Card 2016.Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party.Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.
P2860
Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Combination chemotherapy with ...... tive for plasma cell leukemia.
@ast
Combination chemotherapy with ...... tive for plasma cell leukemia.
@en
Combination chemotherapy with ...... tive for plasma cell leukemia.
@nl
type
label
Combination chemotherapy with ...... tive for plasma cell leukemia.
@ast
Combination chemotherapy with ...... tive for plasma cell leukemia.
@en
Combination chemotherapy with ...... tive for plasma cell leukemia.
@nl
prefLabel
Combination chemotherapy with ...... tive for plasma cell leukemia.
@ast
Combination chemotherapy with ...... tive for plasma cell leukemia.
@en
Combination chemotherapy with ...... tive for plasma cell leukemia.
@nl
P2093
P921
P356
P1476
Combination chemotherapy with ...... tive for plasma cell leukemia.
@en
P2093
Bo Kyoung Seo
Byung Soo Kim
Jeeyong Kim
Seok Jin Kim
Yunjung Cho
P304
P356
10.1093/JJCO/HYM037
P577
2007-05-30T00:00:00Z